Startseite

Welcome to the RTG2740!

The Research Training Group  2740 (“Graduiertenkolleg 2740”) which has started on January 1st 2022, is a research consortium funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) that consists of 11 research groups focusing on the in situ analysis of  micromilieu factors and metabolites in the context of microbial infections (“immunomicrotope”).

The RTG 2740 provides 14 positions per cohort for doctoral candidates in natural science (Dr. rer. nat. candidates) and 4 positions per year for medicine (Dr. med. candidates). The structured training program of the RTG conveys the necessary theoretical knowledge, technical capabilities and general research skills to the doctoral candidates in order to allow for an efficient analysis of the “immunomicrotope” and a successful thesis work. Among other components, it consists of introductory lectures on infectious disease immunology, practical courses and workshops, guest seminars, a doctoral candidates´ jour fixe, an annual retreat, international laboratory exchanges, and participation in the institutional research meetings and journal clubs.

With the help of a thorough supervision strategy the RTG will promote and foster a professional and creative attitude amongst the doctoral candidates, characterized by enthusiasm for science, commitment to the project and the development of own scientific ideas and concepts.


NEWS

We are looking for you!

The RTG 2740 offers 14 PhD positions (f/m/d) starting 01 January 2025

Application deadline: 31 August, 2024

Interviews: 01/02 October, 2024, in Erlangen

 

More information: How to apply – DFG Research Training Group 2740 Immunomicrotope –

 

Interested? – APPLY NOW:  Stellenangebot – Karriere | Uniklinikum Erlangen (uk-erlangen.de)

(link flyer: Flyer RTG 2740-Application_2024_f)

 


Prof. Dr. Aline Bozec receives W3 professorship and is new Head of Research at the Department of Internal Medicine 3

“I am thrilled to announce that I have been promoted to the position of W3 Professor in Experimental Immune Therapy at Friedrich-Alexander-Univeristy Erlangen-Nürnberg by Prof. Joachim Hornegger. My time at FAU has been nothing short of remarkable, surrounded by exceptional colleagues and collaborators who continuously inspire me.

Furthermore, Prof. Georg Schett asked me to take the Head of Research at the Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen. It fills me with great pride to play a more substantial role in the advancement of this exceptional clinic department, and I am eager to contribute further to its development.”

 

 


PD Dr. Heiko Bruns honoured with PRO SCIENTIA-Award

The PRO SCIENTIA Prize – awarded by the Eckhart-Buddecke Foundation for the Promotion of Basic Medical Research in the amount of 10,000 euros – was awarded for the year 2021/2022 to PD Dr. rer. nat. Heiko Bruns (University Hospital Erlangen, Medical Clinic 5, Haematology and Internal Oncology) for the work “β2-microglobulin triggers NLRP3 inflammasome activation in tumour-associated macrophages to promote multiple myeloma progression”, Immunity, 2021; 54(8):1772-1787.

 

 

 


David Barinberg receives Roche lecture prize at 27th Symposium on “Infection and Immune Defense” – Schloss Rothenfels, 2024

David Barinberg won the lecture prize sponsored by Roche at the 27th Symposium on “Infection and Immune Defense” – Schloss Rothenfels (March 04-06, 2024) for his presentation on “IL-5 dependent systemic eosinophilia enables chronification of L. mexicana infection“.

 

 


RTG 2740  1st International Symposium 2023

“ImmunoMicroTope”

June 28-30, 2023, Erlangen

 

Institute of Clinical Microbiology, Immunology and Hygiene, Erlangen

University Hospital of Erlangen and Friedrich-Alexander-University (FAU) Erlangen-Nürnberg

For more information, please click here!